Related Experiment Video
Updated: Nov 22, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
The case for open science: rare diseases
Yaffa R Rubinstein1, Peter N Robinson2, William A Gahl3
1Special Volunteer in the Office of Strategic Initiatives, National Library of Medicine, Bethesda, Maryland, USA.
Abstract:
The premise of Open Science is that research and medical management will progress faster if data and knowledge are openly shared. The value of Open Science is nowhere more important and appreciated than in the rare disease (RD) community. Research into RDs has been limited by insufficient patient data and resources, a paucity of trained disease experts, and lack of therapeutics, leading to long delays in diagnosis and treatment. These issues can be ameliorated by following the principles and practices of sharing that are intrinsic to Open Science. Here, we describe how the RD community has adopted the core pillars of Open Science, adding new initiatives to promote care and research for RD patients and, ultimately, for all of medicine. We also present recommendations that can advance Open Science more globally.
Related Concept Videos
Genomics
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
EPS and iPS Cells in Disease Research
Principles of Disease Surveillance
Lysosomal Hydrolases
Pleiotropy

